Corteva (NYSE:CTVA) Price Target Raised to $100.00 at BMO Capital Markets

Corteva (NYSE:CTVA) had its price target boosted by equities researchers at BMO Capital Markets from $95.00 to $100.00 in a report issued on Monday, Marketbeat reports. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ price objective suggests a potential upside of 26.61% from the stock’s previous close.

Other research analysts have also issued reports about the stock. Barclays raised their price target on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. Wells Fargo & Company boosted their target price on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Deutsche Bank Aktiengesellschaft lifted their price target on Corteva from $90.00 to $100.00 in a report on Monday, May 11th. Oppenheimer raised their price target on shares of Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, July 23rd. Finally, Rothschild & Co Redburn upped their price target on Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $90.86.

Corteva Trading Up 0.3%

Corteva stock opened at $78.98 on Monday. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. Corteva has a 52 week low of $60.53 and a 52 week high of $90.97. The stock has a 50-day moving average price of $82.15 and a 200 day moving average price of $79.63. The company has a market capitalization of $52.83 billion, a price-to-earnings ratio of 52.31, a price-to-earnings-growth ratio of 2.39 and a beta of 0.57.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. During the same quarter last year, the business posted $2.20 EPS. The company’s revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Sell-side analysts anticipate that Corteva will post 3.75 EPS for the current year.

Institutional Trading of Corteva

Large investors have recently made changes to their positions in the company. Drummond Knight Asset Management Pty Ltd purchased a new stake in shares of Corteva in the 4th quarter valued at approximately $25,713,000. Arbejdsmarkedets Tillaegspension purchased a new position in Corteva in the fourth quarter valued at $23,679,000. Leonteq Securities AG acquired a new stake in Corteva in the fourth quarter valued at $2,350,000. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Corteva by 23.5% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock worth $7,378,000 after acquiring an additional 20,957 shares in the last quarter. Finally, Brandes Investment Partners LP raised its position in shares of Corteva by 1.1% during the 4th quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock worth $155,009,000 after acquiring an additional 24,985 shares in the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.